Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Nucor übertrifft Erwartungen im ersten Quartal 2026 – Aktie legt zu (Investing.com DE) +++ NUCOR Aktie +3,63%

ZIMMER BIOMET Aktie

 >ZIMMER BIOMET Aktienkurs 
72.36 EUR    -8.4%    (TradegateBSX)
Ask: 71.34 EUR / 280 Stück
Bid: 71.22 EUR / 280 Stück
Tagesumsatz: 2136 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>ZIMMER BIOMET Performance
1 Woche: -2,5%
1 Monat: +2,3%
3 Monate: +8,6%
6 Monate: -11,0%
1 Jahr: -12,6%
laufendes Jahr: +2,3%
>ZIMMER BIOMET Aktie
Name:  ZIMMER BIOMET HLDGS DL-01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US98956P1021 / 753718
Symbol/ Ticker:  ZIM (Frankfurt) / ZBH (NYSE)
Kürzel:  FRA:ZIM, ETR:ZIM, ZIM:GR, NYSE:ZBH
Index:  S&P500
Webseite:  https://www.zimmerbiomet...
Profil:  Zimmer Biomet Holdings, Inc. is a global medical technology company that designs, manufactures, and markets orthopedic reconstructive products for joint replacement and repair. The company provides a comprehensive portfolio including knee and hip imp..
>Volltext..
Marktkapitalisierung:  15265.62 Mio. EUR
Unternehmenswert:  21349.19 Mio. EUR
Umsatz:  7022.68 Mio. EUR
EBITDA:  2061.86 Mio. EUR
Nettogewinn:  601.55 Mio. EUR
Gewinn je Aktie:  3.04 EUR
Schulden:  6613.6 Mio. EUR
Liquide Mittel:  504.97 Mio. EUR
Operativer Cashflow:  1447.86 Mio. EUR
Bargeldquote:  0.23
Umsatzwachstum:  -5.51%
Gewinnwachstum:  -31.22%
Dividende je Aktie:  0.82 EUR
Dividendenrendite:  1.04%
Dividendenschätzung:  1.04%
Div. Historie:  31.03.26 - 0.2076€
30.12.25 - 0.20424€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  ZIMMER BIOMET
Letzte Datenerhebung:  28.04.26
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 193.57 Mio. St.
Frei handelbar: 99.81%
Rückkaufquote: 2.5%
Mitarbeiter: 17000
Umsatz/Mitarb.: 0.41 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 10.74%
Bewertung:
KGV: 26.08
KGV lG: 10.95
KUV: 2.24
KBV: 1.42
PEG-Ratio: -
EV/EBITDA: 10.35
Rentabilität:
Bruttomarge: 60.94%
Gewinnmarge: 8.57%
Operative Marge: 16.07%
Managementeffizenz:
Gesamtkaprendite: 3.17%
Eigenkaprendite: 5.6%
 >Anleihen 
>Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege, Zahnmedizin/ zahnmedizinische Behandlungen
 
28.04.26 - 16:46
ZBH Q1 Earnings & Revenues Top Estimates, Stock Dips in Pre-Market (Zacks)
 
Zimmer Biomet tops Q1 EPS and revenue estimates with strong segment growth and margin expansion, yet shares slip 1.8% premarket after results....
28.04.26 - 16:46
Zimmer Biomet falls after CEO exit, unchanged growth outlook (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.04.26 - 16:06
Earnings Call Transkript: Zimmer Biomet übertrifft Gewinnprognose für Q1 2026, Aktie fällt dennoch (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
28.04.26 - 15:17
Zimmer Biomet (ZBH) Q1 Earnings and Revenues Top Estimates (Zacks)
 
Zimmer (ZBH) delivered earnings and revenue surprises of +12.57% and +1.84%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?...
28.04.26 - 14:21
Incyte taps Zimmer Biomet′s Suketu Upadhyay as CFO (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.04.26 - 13:24
Zimmer Biomet Holdings CFO Suketu Upadhyay Steps Down, Paul Stellato To Be Interim CFO (AFX)
 
WASHINGTON (dpa-AFX) - Tuesday, Zimmer Biomet Holdings, Inc. (ZBH) announced that Suketu Upadhyay will step down from the position of Chief Financial Officer and Executive Vice President, Finance,......
28.04.26 - 12:54
Zimmer Biomet Holdings Inc. Q1 Profit Climbs (AFX)
 
WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings Inc. (ZBH) released earnings for its first quarter that Increases, from the same period last yearThe company's earnings came in at $238.1 million, or ......
28.04.26 - 12:51
Zimmer Biomet CFO Suketu Upadhyay to depart (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.04.26 - 12:36
Zimmer Biomet Non-GAAP EPS of $2.09 beats by $0.23, revenue of $2.09B beats by $20M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.04.26 - 12:33
Zimmer Biomet Announces Chief Financial Officer Transition (PR Newswire)
 
Suketu Upadhyay to Depart; Paul Stellato Named Interim CFO WARSAW, Ind., April 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced Suketu Upadhyay, Chief Financial Officer and Executive Vice President, Finance,......
28.04.26 - 12:33
Zimmer Biomet Announces First Quarter 2026 Financial Results (PR Newswire)
 
First quarter net sales of $2.087 billion increased 9.3% on a reported basis, 6.8% on a constant currency1 basis and 2.9% on an organic constant currency1 basis First quarter diluted earnings per share were $1.22, an increase of 34.1%; adjusted1 diluted earnings per share were $2.09, an......
27.04.26 - 16:27
Zimmer Biomet Q1 2026 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
22.04.26 - 23:36
Zimmer Biomet (ZBH) Q4 2024 Earnings Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
21.04.26 - 17:30
Zimmer Biomet (ZBH) Earnings Expected to Grow: What to Know Ahead of Next Week′s Release (Zacks)
 
Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
20.04.26 - 16:01
Here′s How Zimmer Biomet Is Placed Ahead of Q1 Earnings (Zacks)
 
ZBH heads into Q1 results with steady EPS estimates, strong knee/hip demand trends and robotics momentum....
09.04.26 - 13:33
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results (PR Newswire)
 
WARSAW, Ind., April 9, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its first quarter earnings conference call will be webcast on Tuesday, April 28, 2026, at 8:30 a.m. ET. A news release detailing the quarterly......
07.04.26 - 13:33
Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer (PR Newswire)
 
Experienced orthopedic surgeon from the Hospital for Special Surgery, innovator and former Chief Medical Technology Advisor joins company in an elevated capacity WARSAW, Ind., April 7, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology......
06.04.26 - 22:06
Inogen Announces the Appointment of Vafa Jamali to Board of Directors (Business Wire)
 
BEVERLY, Mass.--(BUSINESS WIRE)--$INGN #AirwayClearance--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Vafa Jamali as an independent director to the Inogen Board of Directors (the “Board”), effective on the date of the Company's 2026 Annual Meeting, or June 15th if earlier. Mr. Jamali is a long-time medical device executive who will bring added depth and expertise to the Board. During his tenure as the Chief Executive Officer of ZimVie, he led the company's Nasdaq listing following the spin-out from Zimmer Biomet and helped each of the businesses (Spine and Dental) through significant portfolio optimization actions to support a turnaround to higher growth and profitability. Prior to ZimVie, most notably, he spent nearly twelve years at Covidien and Medtronic, where he most recently served as Senior Vice President and President of the Respiratory, Gastrointestinal & Informatics div...
25.03.26 - 15:01
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now? (Zacks)
 
ZBH leans on knee growth, robotics innovation and steady markets, but debt levels and stiff competition complicate its near-term investment appeal....
23.03.26 - 17:12
BTIG downgrades Zimmer Biomet, sees limited upside amid growth challenges (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Am meisten Platz ist zu Hause. - Sprichwort Serbien
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!